GMR Solutions Inc. (GMRS) AI Stock Analysis

GMR Solutions Inc. operates as a provider of emergency medical services (EMS), essential alternate-site, out-of-hospital care, and mobile clinical practice groups in the United States. The company offers emergent medical services, non-emergent services, and related solutions such as membership programs, standby and special events coverage, and a national ambulance contract with the Federal Emergency Management Agency. It also maintains contracts with state agencies and health systems to coordinate EMS responses. GMR Solutions serves health systems, large regional systems, smaller independent hospitals, local communities, payors, public health organizations, and local, state, and federal government agencies. The company was incorporated in 2015 and is based in Lewisville, Texas.

Between FY2023 and FY2025, revenue increased at a two-year CAGR of 3.1%, shifting from $5.39B in FY2023 to $5.98B in FY2024 before decreasing 4.0% to $5.74B in FY2025. Profitability showed steady operational improvement over this timeframe, with operating margin expanding from 7.8% in FY2023 to 12.1% in FY2024 and 14.4% in FY2025. Net income transitioned from -$202.7M in FY2023 to $20.4M in FY2024 and reached $206.2M in FY2025. Over the trailing twelve months ended June 30, 2026, revenue stood at $5.88B with an operating margin of 5.8% and a net margin of 2.8%, alongside quarterly revenue growth of 3.3% year-over-year.

As of June 30, 2026, GMR Solutions held $496.8M in cash and short-term investments alongside total debt of $4.75B, resulting in net debt of $4.26B. Shareholders' equity was $789.3M, yielding a debt-to-equity ratio of 6.02 and a current ratio of 2.01. During FY2025, the company generated $641.1M in operating cash flow and invested $258.5M into capital expenditures, leading to $382.6M in free cash flow. In that same fiscal year, cash deployment toward share repurchases totaled $86,000.

Trading at a last close of $10.00 on October 16, 2026, GMR Solutions has a market cap of $540.2M and an enterprise value of $4.93B. Its valuation multiples stand at a price-to-sales ratio of 0.1x and an EV/EBITDA of 5.2x, both below the median of its US-listed Healthcare peers, which reflect 4.1x and 12.0x, respectively. The stock trades at a price-to-book ratio of 0.8x. Over a one-year timeframe, the S&P 500 returned 16.8%, while the stock traded between a 52-week low of $9.00 and a 52-week high of $15.98.

Wall Street coverage includes 8 ratings: 5 Strong Buy, 2 Buy, and 1 Hold, with no Sell or Strong Sell recommendations. The mean price target is $18.62, representing an 86.2% premium over the last close of $10.00. For the fiscal year ending December 31, 2026, consensus estimates anticipate revenue of $6.03B and EPS of $1.83. For the following fiscal year, 7 analysts project revenue to expand 5.6% to $6.37B, while EPS is estimated to contract 1.9% to $1.80. The next earnings date is November 9, 2026.

This page is an AI-written research summary of GMR Solutions Inc. (GMRS). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: GMRS income statement, GMRS balance sheet, GMRS key metrics, GMRS analyst forecast, GMRS chart. See the GMRS stock overview for the latest quote and news.